I agree with CDiddy, I listened and moved on. This is not about the people, it's about Leronlimab. I want to do everything to give this drug a chance. My guess, 72.4% to 84% will do better with LL, let's get LL into Long Haulers and Severe/Critical in Brazil, HIV and Cancer patients. Let the molecule do the talking.

Still, I do love the "all lab coat, no molecule" comment.